Clarius Group LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $359K | Sell |
4,593
-176
| -4% | -$13.8K | 0.02% | 312 |
|
2025
Q1 | $346K | Sell |
4,769
-78
| -2% | -$5.65K | 0.02% | 311 |
|
2024
Q4 | $359K | Buy |
4,847
+404
| +9% | +$29.9K | 0.02% | 272 |
|
2024
Q3 | $295K | Sell |
4,443
-108
| -2% | -$7.17K | 0.02% | 321 |
|
2024
Q2 | $420K | Sell |
4,551
-111
| -2% | -$10.3K | 0.03% | 242 |
|
2024
Q1 | $446K | Sell |
4,662
-657
| -12% | -$62.8K | 0.03% | 246 |
|
2023
Q4 | $406K | Sell |
5,319
-1,248
| -19% | -$95.2K | 0.03% | 280 |
|
2023
Q3 | $455K | Sell |
6,567
-2,003
| -23% | -$139K | 0.04% | 239 |
|
2023
Q2 | $808K | Buy |
8,570
+389
| +5% | +$36.7K | 0.06% | 170 |
|
2023
Q1 | $677K | Buy |
8,181
+198
| +2% | +$16.4K | 0.06% | 189 |
|
2022
Q4 | $596K | Sell |
7,983
-66
| -0.8% | -$4.93K | 0.05% | 212 |
|
2022
Q3 | $665K | Sell |
8,049
-59
| -0.7% | -$4.88K | 0.07% | 171 |
|
2022
Q2 | $771K | Buy |
8,108
+1,134
| +16% | +$108K | 0.08% | 153 |
|
2022
Q1 | $903K | Hold |
6,974
| – | – | 0.07% | 151 |
|
2021
Q4 | $903K | Buy |
6,974
+59
| +0.9% | +$7.64K | 0.07% | 151 |
|
2021
Q3 | $783K | Buy |
6,915
+258
| +4% | +$29.2K | 0.07% | 152 |
|
2021
Q2 | $689K | Buy |
6,657
+91
| +1% | +$9.42K | 0.06% | 162 |
|
2021
Q1 | $549K | Buy |
6,566
+348
| +6% | +$29.1K | 0.05% | 174 |
|
2020
Q4 | $567K | Buy |
6,218
+1,228
| +25% | +$112K | 0.06% | 157 |
|
2020
Q3 | $398K | Buy |
4,990
+322
| +7% | +$25.7K | 0.05% | 173 |
|
2020
Q2 | $323K | Buy |
4,668
+255
| +6% | +$17.6K | 0.05% | 206 |
|
2020
Q1 | $277K | Sell |
4,413
-204
| -4% | -$12.8K | 0.05% | 189 |
|
2019
Q4 | $364K | Sell |
4,617
-204
| -4% | -$16.1K | 0.06% | 169 |
|
2019
Q3 | $353K | Buy |
4,821
+780
| +19% | +$57.1K | 0.06% | 162 |
|
2019
Q2 | $249K | Buy |
4,041
+588
| +17% | +$36.2K | 0.05% | 202 |
|
2019
Q1 | $220K | Buy |
+3,453
| New | +$220K | 0.05% | 186 |
|